Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

about

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

Item

http://www.wikidata.org/entity/Q55359715

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@en

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@nl

type

Item

label

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@en

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@nl

prefLabel

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@en

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@nl

P1476

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia.

@en

P2093

Efstathios Kastritis

http://www.w3.org/2001/XMLSchema#string

Maria Gavriatopoulou

http://www.w3.org/2001/XMLSchema#string

Meletios Athanasios Dimopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.

P304

12536-12537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.18632/ONCOTARGET.23400

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29560081

http://www.w3.org/2001/XMLSchema#string

P932

5849145

http://www.w3.org/2001/XMLSchema#string